Active — Not RecruitingNot Applicable

CB1R in Synthetic Psychoactive Cannabinoids

United States15 participantsStarted 2018-05-01

Plain-language summary

The purpose of this research study is to determine whether the CB1R availability is lower in synthetic psychoactive cannabinoid subjects using the most widely available synthetic psychoactive cannabinoids at the time the study is initiated.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: * Able to provide written consent * Age 18-55 * Current Synthetic Psychoactive Cannabinoids consumption Exclusion: * MRI metal exclusions and claustrophobia * Education completed is less than 12 years

What they're measuring

Positron Emission Tomography (PET Imaging)

Timeframe: Change in CB1R availability from baseline throughout one test day

Trial details

NCT IDNCT03539575

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

View on ClinicalTrials.gov More Drug Dependence trials